hydroxychloroquine has been researched along with Nephrotic Syndrome in 6 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Nephrotic Syndrome: A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The patient received induction therapy with steroids, cyclophosphamide and hydroxychloroquine followed by rapid clinical improvement and remission of proteinuria." | 3.96 | A case report of hypocomplementemic urticarial vasculitis presenting with membranoproliferative glomerulonephritis. ( Boletis, JN; Liapis, G; Marinaki, S; Skalioti, C; Vallianou, K, 2020) |
| "A 30 year old lady patient of SLE on steroid and hydroxychloroquine therapy presented with lupus nephritis and later developed cardiac symptoms." | 3.79 | Hydroxychloroquine-induced phospholipidosis in a case of SLE: the wolf in zebra clothing. ( Bichle, LS; Khubchandani, SR, 2013) |
| " Complete remission of the nephrosis occurred after discontinuation of hydroxychloroquine therapy." | 3.66 | Membranous nephropathy in rheumatoid arthritis. ( Figueroa, JE; Waxman, J, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Li, R | 1 |
| Zhang, C | 1 |
| Wang, H | 1 |
| An, Y | 1 |
| Vallianou, K | 1 |
| Skalioti, C | 1 |
| Liapis, G | 1 |
| Boletis, JN | 1 |
| Marinaki, S | 1 |
| Serre, J | 1 |
| Buob, D | 1 |
| Boffa, JJ | 1 |
| Khubchandani, SR | 1 |
| Bichle, LS | 1 |
| Shahane, A | 1 |
| Khasnis, A | 1 |
| Gota, C | 1 |
| Figueroa, JE | 1 |
| Waxman, J | 1 |
6 other studies available for hydroxychloroquine and Nephrotic Syndrome
| Article | Year |
|---|---|
Breastfeeding by a mother taking cyclosporine for nephrotic syndrome.
Topics: Adult; Breast Feeding; Cyclosporine; Female; Humans; Hydroxychloroquine; Infant; Mothers; Nephrotic | 2022 |
A case report of hypocomplementemic urticarial vasculitis presenting with membranoproliferative glomerulonephritis.
Topics: Aged; Antirheumatic Agents; Arthritis; Chronic Urticaria; Complement System Proteins; Cyclophosphami | 2020 |
Hydroxychloroquine-induced podocytopathy mimicking Fabry disease.
Topics: Adult; Antirheumatic Agents; Diagnosis, Differential; Fabry Disease; Female; Humans; Hydroxychloroqu | 2019 |
Hydroxychloroquine-induced phospholipidosis in a case of SLE: the wolf in zebra clothing.
Topics: Adult; Antirheumatic Agents; Cyclophosphamide; Female; Glucocorticoids; Humans; Hydroxychloroquine; | 2013 |
Rituximab-responsive nephrotic syndrome due to minimal change disease in systemic lupus erythematosus.
Topics: Adolescent; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Diuretics; Drug Therapy, C | 2012 |
Membranous nephropathy in rheumatoid arthritis.
Topics: Adult; Arthritis, Rheumatoid; Glomerulonephritis; Humans; Hydroxychloroquine; Kidney Glomerulus; Mal | 1982 |